Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2013
12/24/2013US8614255 Pulmonary pharmaceutical formulations
12/24/2013US8614232 Injectable depot formulation comprising crystals of iloperidone
12/24/2013US8613946 Carotenoids of enhanced bioavailability
12/24/2013US8613929 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers
12/24/2013CA2783175C Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
12/24/2013CA2759060C A drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic
12/24/2013CA2706512C Compositions and devices
12/24/2013CA2644035C Process for producing a solid dispersion of an active ingredient
12/24/2013CA2623529C Pdgf amphiphilic polymer complex
12/24/2013CA2608505C Colonic delivery of adsorbents
12/24/2013CA2601784C Acylated glp-1 compounds
12/24/2013CA2557369C Liquid, peg-free, cold-processable oil-in-water emulsifiers obtainable by combining emulsifiers based on polyol partial esters and acid partial esters
12/24/2013CA2545939C Immunoglobulin preparations having increased stability
12/24/2013CA2493834C Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/24/2013CA2375104C Prevention and treatment of amyloidogenic disease
12/19/2013WO2013188763A1 Compositions for treating cancer and methods for making the same
12/19/2013WO2013188740A1 Anti-psma antibodies conjugated to nuclear receptor ligand polypeptides
12/19/2013WO2013188681A1 Polymeric treatment compositions
12/19/2013WO2013188529A1 Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium
12/19/2013WO2013188279A1 Topical ophthalmological pharmaceutical composition containing cediranib
12/19/2013WO2013188273A1 Topical ophthalmological pharmaceutical composition containing axitinib
12/19/2013WO2013188268A1 Topical ophthalmological pharmaceutical composition containing pazopanib
12/19/2013WO2013188217A1 Therapeutic formulation and methods of treatment
12/19/2013WO2013187795A1 Pharmaceutical composition of an s1p receptor agonist for treating demyelinized disorders
12/19/2013WO2013187700A1 Pharmaceutical combined formulation comprising metformin and hmg-coa reductase inhibitor
12/19/2013WO2013187451A1 Patch
12/19/2013WO2013187391A1 COMPOSITION COMPRISING SESAMIN COMPOUND, γ-ORIZANOL AND RICE GERM OIL
12/19/2013WO2013187088A1 Method for producing powder for inhalation
12/19/2013WO2013186793A1 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
12/19/2013WO2013186700A1 Antibody formulation
12/19/2013WO2013186632A2 Conjugates of biologically active molecules to functionalized polymers
12/19/2013WO2013186545A2 Recombinant polypeptide
12/19/2013WO2013186320A1 Pharmaceutical composition comprising crystalline posaconazole
12/19/2013WO2013186230A1 Pharmaceutical formulation for a therapeutic antibody
12/19/2013WO2013186138A1 Preparation comprising insulin, nicotinamide and arginine
12/19/2013WO2013185934A1 Method of preparing a composition based on hyaluronic acid
12/19/2013WO2013185241A1 Aptamers specific to cea and tnf-alpha and their therapeutic uses
12/19/2013WO2013185235A1 Targeted iduronidase compounds
12/19/2013WO2013185215A1 Antibodies and conjugates that target misfolded prion protein
12/19/2013WO2013142255A3 Bi-specific binding agents
12/19/2013WO2013093465A3 Formulations
12/19/2013WO2003057278A3 Drug delivery system for sustained delivery of glipizide
12/19/2013US20130338569 Polymeric hydrogel compositions which release active agents in response to electrical stimulus
12/19/2013US20130338240 Use of a viscoelastic fluid for producing a medicinal product for surgically treating the eye
12/19/2013US20130338237 Preparation of brushite and octacalcium phosphate granules
12/19/2013US20130338236 Sanitizer compositions comprising alcohol and an antimicrobial efficacy enhancer
12/19/2013US20130338210 Compositions for nucleic acid delivery
12/19/2013US20130338204 Oligomer-Dantrolene Conjugates and Related Compounds
12/19/2013US20130338175 Multi-Arm Polymeric Prodrug Conjugates of Pemetrexed-Based Compounds
12/19/2013US20130338164 Multimeric VLA-4 Antagonists Comprising Polymers Moieties
12/19/2013US20130338143 Compositions for Transdermal Delivery of Active Agents
12/19/2013US20130338123 Natural combination hormone replacement formulations and therapies
12/19/2013US20130338118 Compounds for treatment of heart failure
12/19/2013US20130338103 Treatment of cancer
12/19/2013US20130338088 Self solidifying bioerodible barrier implant
12/19/2013US20130338083 Methods of providing therapeutic effects using cyclosporin components
12/19/2013US20130338069 Preparation of a Therapeutic Composition
12/19/2013US20130338065 Dry powder inhaler and system for drug delivery
12/19/2013US20130338060 Liquid medicinal composition containing echinocandin antifungal agent micafungin
12/19/2013US20130337549 Materials and methods for nerve grafting
12/19/2013US20130337534 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation
12/19/2013US20130337078 Particulate constructs for release of active agents
12/19/2013US20130337075 Nanomedicines for early nerve repair
12/19/2013US20130337071 Radiofrequency-induced synchronization of in situ hyperthermia and chemotherapy via magnetic-nanoconjugates
12/19/2013US20130337068 Carotenoid particles and uses thereof
12/19/2013US20130337064 Pharmaceutical composition
12/19/2013US20130337041 Charged phospholipid compositions and methods for their use
12/19/2013US20130337039 Internalizing ErBB2 Antibodies
12/19/2013US20130337036 Method of using fibrous tissue sealant
12/19/2013US20130337029 Cured oil-hydrogel biomaterial compositions for controlled drug delivery
12/19/2013US20130337024 Carotenoid-containing composition and method for producing the same
12/19/2013US20130337021 Percutaneous absorption preparation comprising anti-dementia drug
12/19/2013US20130337005 Nanoparticles for providing immune responses against infectious agents
12/19/2013US20130337004 Polysaccharide-protein conjugate vaccines
12/19/2013US20130336994 Extracellular targeted drug conjugates
12/19/2013US20130336955 Antimicrobial fusion compounds and uses thereof
12/19/2013US20130336915 Particulate constructs for release of active agents
12/19/2013US20130336903 Personal Care Compositions Comprising a pH Tuneable Gellant and Methods of Using
12/19/2013US20130336902 Personal Care Compositions Comprising a Di-Amido Gellant and Methods of Using
12/19/2013US20130336892 Chimeric t1r taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric t1r polypeptides
12/19/2013US20130336884 Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
12/19/2013DE102010023850B4 Funktionalisierte Nanopartikel mit verbesserter Bioverfügbarkeit Functionalized nanoparticles with improved bioavailability
12/19/2013CA2877715A1 Topical ophthalmological pharmaceutical composition containing axitinib
12/19/2013CA2877710A1 Topical ophthalmological pharmaceutical composition containing pazopanib
12/19/2013CA2877678A1 Topical ophthalmological pharmaceutical composition containing cediranib
12/19/2013CA2877505A1 Antibodies and conjugates that target misfolded prion protein
12/19/2013CA2876706A1 Anti-psma antibodies conjugated to nuclear receptor ligand polypeptides
12/19/2013CA2876525A1 Targeted iduromdase compounds
12/19/2013CA2876474A1 Polymeric treatment compositions
12/19/2013CA2876315A1 Conjugates of biologically active molecules to functionalized polymers
12/19/2013CA2876070A1 Method of preparing a composition based on hyaluronic acid
12/19/2013CA2875386A1 Antibody formulation
12/19/2013CA2874761A1 Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo
12/19/2013CA2840372A1 Method for producing powders for inhalation
12/18/2013EP2674440A2 Multivalent immunoglobulin-based bioactive assemblies
12/18/2013EP2674152A1 Stable liquid oily ready-to-use formulations, preparation thereof and use thereof
12/18/2013EP2674149A1 Method for preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation
12/18/2013EP2674147A1 Hyaluronic acid-based gels including anesthetic agents
12/18/2013EP2673294A1 Mutant interleukin-2 polypeptides
12/18/2013EP2673006A2 Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 1712